--- 
layout: page 
image:
  feature: DaubEnginePatent.jpg
--- 
   <head>
      <title>2435-</title>
      <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
</head>
      <li><a href="index.html">Manual of Patent Examining Procedure</a></li>
      <li><a href="mpep-2400.html"><span>Chapter 2400</span></a></li>
      <li><span>Section 2435</span></li>  </ul>  </div>
      <div id="yui-main">
         <div class="yui-b">
            <div class="yui-g">  <div xmlns:bf="http://www.uspto.gov/bf" id="article">
               <div>
                  <div xmlns="" class="Section" id="d0e247839">
                     <h1 class="page-title">2435
                        &nbsp;&nbsp;
                        Publishing of Patents and Patent Application Publications with
                        Lengthy Sequence Listings [R-08.2012]
                     </h1>
                     <p id="d0e247843"> Due to the high cost and limited
                        usefulness of the printed paper or composed electronic image versions of nucleotide and/or
                        amino acid sequences, if the “Sequence Listing” portion is lengthy (i.e., at least 600 Kb
                        (about 300 typed pages)), it will no longer be printed with the paper and composed
                        electronic image (page image) versions of patents and patent application publications. The
                        “Sequence Listing” will only&nbsp;be published in electronic form and will be&nbsp;available&nbsp;on the
                        USPTO sequence homepage (http://seqdata.uspto.gov) as an ASCII text file. 
                     </p>
                     <p id="d0e247846"> Neither the paper copies of patents
                        and patent application publications that are in the search rooms nor those sold through the
                        Office of Public Records, Certification Division, will include a sequence listing if the
                        sequence listing is not included in the composed electronic image (page image) version of
                        the patent or patent application publication. Furthermore, any copy used as a reference in
                        an Office action will include only the paper portion of the document. If an applicant
                        requires an electronic copy of a “Sequence Listing” that was not printed in the document,
                        applicant must specifically request and pay for the electronic copy. Both applicants and
                        members of the general public can obtain an electronic copy of the “Sequence Listing”
                        through the Certification Division for a separate fee as set forth in <b><a href="mpep-9020-appx-r.html#d0e315991">37 CFR
                              1.19(b)(3)</a></b>. See the paragraph entitled “Copies of Documents” in
                        <b><a href="s1730.html#d0e163385">MPEP §
                              1730</a></b> for contact information for Certification Division. 
                     </p>
                     <p id="d0e247855">The patent mailed to applicant will
                        include a copy of the patent on paper and a copy of the sequence listing on an electronic
                        medium (e.g., compact disc), if the “Sequence Listing” is not printed in the patent. 
                     </p>
                     <p id="d0e247858"> If the “Sequence Listing” is not
                        included in the page images of a patent or patent application publication, a standardized
                        statement will appear. Additionally, in the electronic text version of the patent or patent
                        application publication, the statement will include an active hyperlink to a web page
                        containing the “Sequence Listing.” The standardized statement for a patent will read, for
                        example:
                     </p>
                     <div id="d0e247861" class="Example"><b>SEQUENCE LISTING</b><p id="d0e247865">The patent contains a lengthy
                           “Sequence Listing” section. A copy of the “Sequence Listing” is available in electronic
                           form from the USPTO web site (http://seqdata.uspto.gov/sequence.html?DocID=6183957B1).
                           An electronic copy of the “Sequence Listing” will also be available from the USPTO upon
                           request and payment of the fee set forth in <b><a href="mpep-9020-appx-r.html#d0e315991">37 CFR
                                 1.19(b)(3)</a></b>.
                        </p>
                     </div>
                     <p id="d0e247871">The standardized statement for a patent
                        application publication will read, for example:
                     </p>
                     <div id="d0e247874" class="Example"><b>SEQUENCE LISTING</b><p id="d0e247878">The patent application contains a
                           lengthy “Sequence Listing” section. A  copy  of the “Sequence Listing” is  available in
                           electronic  form  from the USPTO web site
                           (http://seqdata.uspto.gov/sequence.html?DocID=20010000241). An electronic copy of the
                           “Sequence Listing” will also be available from the USPTO upon request and payment of the
                           fee set forth in <b><a href="mpep-9020-appx-r.html#d0e315991">37 CFR 1.19(b)(3)</a></b>.
                        </p>
                     </div>
                     <p id="d0e247884"> Sequence data may also be accessed in
                        a more&nbsp;readily searchable manner from the National Center for Biotechnology Information
                        (NCBI) at http://www.ncbi.nlm.nih.gov or from a commercial vendor. The USPTO forwards a
                        copy of the sequence data to NCBI when a patent including a “Sequence Listing” is granted,
                        and when an application containing a sequence is published pursuant to <b><a href="mpep-9015-appx-l.html#d0e303054">35 U.S.C.
                              122(b)</a></b>. If NCBI elects to include the sequence data in one of its
                        databases, NCBI indexes the sequence data according to patent or patent application
                        publication number. There is currently no fee for the public to use the NCBI
                        site.
                     </p>
                     <p align="right"><a href="#top">[top]</a></p>
                  </div>
               </div>
               <div>
                  <h1 class="page-title">&nbsp;</h1>
               </div>  </div>
            </div>
         </div>
      </div>
      <div class="yui-b">
         <div id="aside">  <div id="rdms-sub-nav-container" xmlns:bf="http://www.uspto.gov/bf">
            <ul id="sub-nav">
               <li xmlns=""><a href="s2401.html">2401-Introduction</a></li>
               <li xmlns=""><a href="s2402.html">2402-The Deposit Rules</a></li>
               <li xmlns=""><a href="s2403.html">2403-Deposit of Biological Material</a><ul>
                     <li><a href="s2403.html#d0e240728">2403.01-Material Capable of Self- Replication</a></li>
                     <li><a href="s2403.html#d0e240735">2403.02-Plant Material</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2404.html">2404-Need or Opportunity to Make a Deposit</a><ul>
                     <li><a href="s2404.html#d0e240816">2404.01-Biological Material That Is Known and Readily Available to the Public</a></li>
                     <li><a href="s2404.html#d0e240930">2404.02-Biological Material That Can Be Made or Isolated Without Undue Experimentation</a></li>
                     <li><a href="s2404.html#d0e240946">2404.03-Reference to a Deposit in the Specification</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2405.html">2405-Acceptable Depository</a></li>
               <li xmlns=""><a href="s2406.html">2406-Time of Making an Original Deposit</a><ul>
                     <li><a href="s2406.html#d0e241742">2406.01-Description in Application Specification</a></li>
                     <li><a href="s2406.html#d0e241769">2406.02-Deposit After Filing Date - Corroboration</a></li>
                     <li><a href="s2406.html#d0e241779">2406.03-Possible Loss of U.S. Filing Date in Other Countries</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2407.html">2407-Replacement or Supplement of Deposit</a><ul>
                     <li><a href="s2407.html#d0e241898">2407.01-In a Pending Application</a></li>
                     <li><a href="s2407.html#d0e241922">2407.02-After a Patent Has Issued</a></li>
                     <li><a href="s2407.html#d0e241949">2407.03-Failure to Replace</a></li>
                     <li><a href="s2407.html#d0e241964">2407.04-Treatment of Replacement</a></li>
                     <li><a href="s2407.html#d0e241982">2407.05-Exemption From Replacement</a></li>
                     <li><a href="s2407.html#d0e241992">2407.06-Replacement May Not Be Recognized</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2408.html">2408-Term of Deposit</a></li>
               <li xmlns=""><a href="s2409.html">2409-Viability of Deposit</a></li>
               <li xmlns=""><a href="s2410.html">2410-Furnishing of Samples</a><ul>
                     <li><a href="s2410.html#d0e242157">2410.01-Conditions of Deposit</a></li>
                     <li><a href="s2410.html#d0e242206">2410.02-Certification of Statement of Availability of Deposit</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2411.html">2411-Examination Procedures</a><ul>
                     <li><a href="s2411.html#d0e242312">2411.01-Rejections Based on Deposit Issue</a></li>
                     <li><a href="s2411.html#d0e242401">2411.02-Replies to Rejections Based on Deposit Issue</a></li>
                     <li><a href="s2411.html#d0e242424">2411.03-Application in Condition for Allowance Except for Deposit</a></li>
                     <li><a href="s2411.html#d0e242459">2411.04-After a Patent Has Been Granted</a></li>
                     <li><a href="s2411.html#d0e242505">2411.05-Content of Application with Respect to Deposited Material</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2412-2419.html">2412-2419-[Reserved]</a></li>
               <li xmlns=""><a href="s2420.html">2420-The Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures - the Sequence
                     Rules</a></li>
               <li xmlns=""><a href="s2421.html">2421-Overview of the Sequence Rules</a><ul>
                     <li><a href="s2421.html#d0e242552">2421.01-Applications Affected</a></li>
                     <li><a href="s2421.html#d0e242568">2421.02-Summary of the Requirements of the Sequence Rules</a></li>
                     <li><a href="s2421.html#d0e242594">2421.03-Notification of a Failure to Comply</a></li>
                     <li><a href="s2421.html#d0e242622">2421.04-Future Changes to the Sequence Rules</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2422.html">2422-Nucleotide and/or Amino Acid Sequence Disclosures in Patent Applications</a><ul>
                     <li><a href="s2422.html#d0e245121">2422.01-Definitions of Nucleotide and/or Amino Acids for Purpose of Sequence Rules</a></li>
                     <li><a href="s2422.html#d0e245175">2422.02-The Requirement for Exclusive Conformance; Sequences Presented in Drawing Figures</a></li>
                     <li><a href="s2422.html#d0e245191">2422.03-The Requirements for a Sequence Listing and Sequence Identifiers; Sequences Embedded in Application Text; Variants of a Presented
                           Sequence</a></li>
                     <li><a href="s2422.html#d0e245299">2422.04-The Requirement for a Computer Readable Copy of the Official Copy of the Sequence Listing</a></li>
                     <li><a href="s2422.html#d0e245330">2422.05-Reference to Previously Filed Identical Computer Readable Form; Continuing or Derivative Applications; Request for Transfer
                           of Computer Readable Form</a></li>
                     <li><a href="s2422.html#d0e245358">2422.06-Requirement for Statement Regarding Content of Official and Computer Readable Copies of Sequence Listing</a></li>
                     <li><a href="s2422.html#d0e245376">2422.07-Requirements for Compliance, Statements Regarding New Matter, and Sanctions for Failure to Comply</a></li>
                     <li><a href="s2422.html#d0e245454">2422.08-Presumptions Regarding Compliance</a></li>
                     <li><a href="s2422.html#d0e245470">2422.09-Box Sequence; Hand Delivery of Sequence Listings and Computer Readable Forms</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2423.html">2423-Symbols and Format To Be Used for Nucleotide and/or Amino Acid Sequence Data</a><ul>
                     <li><a href="s2423.html#d0e245579">2423.01-Format and Symbols To Be Used in Sequence Listings</a></li>
                     <li><a href="s2423.html#d0e245618">2423.02-Depiction of Coding Regions</a></li>
                     <li><a href="s2423.html#d0e245637">2423.03-Presentation and Enumeration of Sequences</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2424.html">2424-Requirements for Nucleotide and/or Amino Acid Sequences as Part of the Application Papers</a><ul>
                     <li><a href="s2424.html#d0e246252">2424.01-Informational Requirements for the Sequence Listing</a></li>
                     <li><a href="s2424.html#d0e246289">2424.02-Sequence Listing Numeric Identifiers</a></li>
                     <li><a href="s2424.html#d0e246838">2424.03-Additional Miscellaneous Requirements</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2425.html">2425-Form and Format for Nucleotide and/or Amino Acid Sequence Submissions in Computer Readable Form</a></li>
               <li xmlns=""><a href="s2426.html">2426-Amendments to or Replacement of Sequence Listing and Computer Readable Copy Thereof</a></li>
               <li xmlns=""><a href="s2427.html">2427-Form Paragraphs and Notice to Comply</a><ul>
                     <li><a href="s2427.html#d0e247062">2427.01-Form Paragraphs</a></li>
                     <li><a href="s2427.html#d0e247506">2427.02-Notice To Comply</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2428.html">2428-Sample Statements</a></li>
               <li xmlns=""><a href="s2429.html">2429-Helpful Hints for Compliance</a></li>
               <li xmlns=""><a href="s2430.html">2430-PatentIn Information; Utilities Programs; Training</a></li>
               <li xmlns=""><a href="s2431.html">2431-Sample Sequence Listing</a></li>
               <li xmlns=""><a href="s2432-2433.html">2432-2433-[Reserved]</a></li>
               <li xmlns=""><a href="s2434.html">2434-Examination of Patent Applications Claiming Large Numbers of Nucleotide Sequences</a></li>
               <li xmlns=""><a href="s2435.html">2435-Publishing of Patents and Patent Application Publications with Lengthy Sequence Listings</a></li>
            </ul>  </div>
         </div>
      </div>  </div>
      <!-- Footer Navigation: /includes/general/footer2.html -->

<!-- Used in: MPEP, CPC -->

<!-- ID = $Id: footer2.html 3354 2013-04-23 18:43:33Z janaki $ -->

<!-- URL = $URL: https://dev-wmb-svn.etc.uspto.gov/repos/live/active_content/trunk/includes/general/footer2.html $ -->





  <div style="text-align:right"> Last Modified: 

     

    03/27/2014 10:10:34 

  </div>

</div>

</div>




<!-- End of footer2.html -->


   </body>
</html>